Rechèch (Nouvèl)

Immutrin Appoints Leading Cardiovascular Drug Development Expert Dr. Robert Blaustein As Chief Medical Officer And Establishes US Subsidiary

english top health

(MENAFN - GlobeNewsWire - Nasdaq) Former Edgewise and Merck leader brings more than 15 years' experience to guide Immutrin's clinical strategy as the Company advances towards first-in-human studies ...
2026-05-06 02:01:55